openPR Logo
Press release

GlobalData: Migraine – Pipeline Assessment and Market Forecasts to 2016 on reports-research.com

08-09-2010 05:25 PM CET | Health & Medicine

Press release from: dynamic technologies Gmbh, Köln, Germany

Global Migraine Market Forecast, 2001-2016

Global Migraine Market Forecast, 2001-2016

GlobalData’s new report Migraine - Pipeline Assessment and Market Forecasts to 2016 is an essential source of information and analysis on the global migraine market. The report identifies the key trends shaping and driving the global migraine market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioningos of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global migraine sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

The Migraine Market Has Declined Since 2009 and This Decline is Forecast to Continue until 2016

GlobalData estimated the global migraine market to be worth $3.8 billion in 2009. It is forecast to decrease at a Compound Annual Growth Rate (CAGR) of -3% over the next seven years to reach $3.1 billion by 2016. This decrease in the growth rate can be primarily attributed to the increased competition among the existing products, the patent expiries of standard triptans, the availability of prophylactic drugs, the accessibility of cheaper pain relievers, a weak pipeline with limited drugs and high levels of patient satisfaction with generic and me-too drugs. The migraine market finished its mature phase in 2009 and has since entered into a declining phase in terms of revenue. This decline is expected to continue to 2016. Until 2008, GlaxoSmithKline led the migraine market with its blockbuster drug Imitrex. On August 6, 2008, Imitrex lost its patent exclusivity, which decreased its sales from $1 billion to less than $200m in 2009.

Migraine Competitive Landscape Remains Static

GlobalData has found that GlaxoSmithKline plc. (GSK), Eli Lilly and Company, Merck & Co., Inc., Pozen, Inc., Eisai Co., Ltd., Johnson & Johnson, NuPathe Inc. and Abbott Laboratories are the leading competitors in the global migraine market. Together, these companies accounted for more than 40% of the global migraine market in 2009. The rest of the market was held by generic versions and prophylactic migraine drugs that include beta blockers, calcium channel blockers, anti-depressants and anticonvulsants. After the expiry of the patent on GSK’s Imitrex in mid 2008, the migraine market declined sharply. Until the end of 2007, Imitrex was the market leader, generating revenues worth more than $1.5 billion. GSK had three approved drugs in the migraine market until the end of 2008. Due to the expiry of these three drugs’ patents, GSK’s revenues in the migraine market will decline until its pipeline drugs are launched.

Current Treatment Options are Moderately Successful in Meeting the Market Demand

GlobalData’s analysis has found that the current competition in the migraine market is weak and the available treatment options have been fairly successful in meeting the market demand. The products currently available in the market have disease modifying properties and show pain relief approximately two hours after dosage. There are many other drugs approved for the prevention of migraine headaches. The migraine market has already finished its mature phase and entered into a declining phase by incorporating many generic drugs that drive the current market.

The Pipeline is Weak and Mainly Consists of Me-Too Drugs

GlobalData found that 99 therapies were in different developmental stages in 2009. More than 60% of the pipeline drugs are either me-too drugs or generic drugs. However, the prevailing market landscape remains dominated by a small number of market players which moderately fulfill the unmet needs that exist in the market. Some products, currently under clinical investigations, are expected to receive regulatory agencies’ marketing approval by 2013. Considering the fact that the majority of products belong to the same class as the existing products and only offer minute improvements in terms of safety and efficacy profiles, the existing market leaders will not face significant challenges to their market shares. The global migraine market is heading towards a static competitive landscape.

Migraine Competitive Landscape Remains Static

GlobalData has found that 99 products were in different developmental stages in 2009. Of these, approximately 14% are first-in-class products in different stages of clinical development. AST-726, Tonabersat, and GW274150 are the first-in-class drugs under Phase II clinical studies. All the drugs in Phase III clinical studies are either me-toos or generics. The majority of the pipeline products do not differ from the marketed ones in terms of addressing the unmet clinical needs. The competitive landscape is populated by six major products, two of which are by GSK and one is by AstraZeneca. Imitrex, GSK’s leading triptan drug, lost its patent exclusivity in 2008. Amerge, GSK’s other leading migraine drug, will be off patent by July 7, 2010. The revenues of Amerge declined drastically in 2009. Any company that develops drugs with effective mechanisms and significantly improved safety profiles will emerge as a strong competitor and is likely to capture a significant share of the migraine market.

GlobalData: Migraine - Pipeline Assessment and Market Forecasts to 2016:
http://www.reports-research.com/market-surveys/migraine-pipeline-assessment-market-forecasts-2016-p-111105.html

GlobalData: More market data and market reports:
http://www.reports-research.com/studien/globaldata-m-304.html

markt-studie.de, founded in 2002 has emerged as a leading online portal for market surveys and market research in German speaking areas. Four years later the English language portal reports-research.com was introduced due to the extraordinary success of the portal. Again one year later estudio-mercado.es - the Spanish spoken portal - was founded. The objective of the three portals is to competently and efficiently support consultants and decision makers in management, sales and marketing in the search for worldwide market research. Prospective buyers can look into more than 60,000 market surveys from more than 200 international publishers, current market data for more than 6,000 branches worldwide, 10,000 company profiles as well as a free-of-charge research and recommendation service for individual market research.

Contact:

reports-research.com
c/o dynamic technologies GmbH
Siegburger Str. 233
50679 Köln
Germany

Manuel Bravo Sanchez (CEO)

info@reports-research.com
or
Tel ++49 (0)221 677 897 32
Fax ++49 (0)221 677 897 34

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release GlobalData: Migraine – Pipeline Assessment and Market Forecasts to 2016 on reports-research.com here

News-ID: 140873 • Views:

More Releases from dynamic technologies Gmbh, Köln, Germany

Canadean: New Zealand - The Future of Foodservice to 2016
Canadean: New Zealand - The Future of Foodservice to 2016
The New Zealand foodservice market recorded a CAGR of 1.43% during the review period. Per capita sales increased at a review period CAGR of 0.38%. In 2011, the profit sector contributed 92.1% to the country’s total foodservice sales and posted a per capital sales CAGR of 0.33%. Growth in the profit sector is attributable to the growth in the restaurant channel which grew by a CAGR of 1.56%. In
yStats.com: South Korea B2C E-Commerce Report 2011 published on reports-research.com
yStats.com: South Korea B2C E-Commerce Report 2011 published on reports-research …
The latest South Korea B2C E-Commerce Report 2011, compiled by Hamburg-based market research firm yStats.com features important B2C E-Commerce facts and figures on South Korea. In addition to revenue figures, market shares and customers, the report also covers general online use, the latest trends and major competitors. In 2010, the number of internet users in South Korea rose to more than 35 million. Growth rates were very low in the last
yStats.com: Turkey Top 100 E-Commerce Players 2011 published on reports-research.com
yStats.com: Turkey Top 100 E-Commerce Players 2011 published on reports-research …
The latest and highly informative Turkey Top 100 E-Commerce Players 2011 ranking, compiled by the Hamburg-based market research firm yStats com, presents the 100 most successful players on the Turkish E-Commerce market. Turkey’s top 100 E-Commerce players have been ranked based on local unique visitor numbers from September 2011. The yStats com ranking highlights important details about competitors in the Turkish E-Commerce sector, shareholders, business models, product ranges, local and
GlobalData: Wind Power - Global Market Size, Turbine Market Share, Installation Prices, Regulations and Investment Analysis to 2020
GlobalData: Wind Power - Global Market Size, Turbine Market Share, Installation …
Wind Power - Global Market Size, Turbine Market Share, Installation Prices, Regulations and Investment Analysis to 2020 is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Global Wind Power market. The research provides an understanding of the technology, key drivers and challenges in the global wind power market. It also provides historical and forecast data to 2020 for installed capacity and power

All 5 Releases


More Releases for Migraine

Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help